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A New Questionnaire to Determine the Frequency and Severity of Symptoms Caused by  
Inhaled Odors, Chemicals and Irritants in Normal Subjects and Their Relation to Health- 
Related Quality of Life 
 
Stephen E. Williamson, M.D. 
 
ABSTRACT  
Abstract 
Individuals may develop symptoms in response to inhaled odors, chemicals, and irritants.  
This may affect their quality of life.  Little is known about the prevalence and severity of 
symptoms that result from exposure to odors, chemicals and irritants.  This study 
demonstrates the development of a new respiratory questionnaire to detect the prevalence 
and severity of symptoms experienced upon exposure to chemicals, odors, and irritants, and 
relates these symptoms to quality of life.  This questionnaire was submitted to 96 volunteers 
at the University of South Florida College of Public Health who responded to items 
regarding symptoms developed in response to exposure to automobile exhaust, cigarette 
smoke, strong smells, cologne, perfumes or scented candles, or fresh paint vapors or fumes.  
Health-related quality of life was assessed using a subscale included with the questionnaire.  
The number and severity of symptoms developed in response to exposure to odors, 
chemicals, and irritants showed a strong negative correlation with health-related quality of 
life, consistent with intuitive estimates of the direction of this relationship.  Also, it was 
shown that in normal populations, males and females develop statistically similar prevalence 
and severity of symptoms in response to exposure to odors, chemicals, and irritants.  
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Hypothesis and Specific Aims 
 
Hypothesis 
 
The frequency and severity of symptoms reported by those who are exposed to inhaled 
odors, chemicals and irritants can be determined by a self-administered questionnaire, and 
these symptoms affect their reported quality of life. 
 
Specific Aims 
 
I:  To develop a self-administered questionnaire and demonstrate that it detects the 
frequency and severity of symptoms reported by normal individuals on their experience with 
odors, chemicals, and irritants. 
 
II:  To determine the relationship between self-reported quality of life and severity of 
reported symptoms in normal individuals' experience with inhaled odors, chemicals, and 
irritants. 
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Introduction  
 
Questionnaires are an important and powerful tool to explore occupational health problems.  
They are easy to apply, inexpensive to administer, and readily interpretable.  The proper use 
of a questionnaire is dependent on careful design, subsequent verification of validity and 
reproducibility, and the close monitoring of its application.1  Here, we will demonstrate the 
creation of a questionnaire and its use to determine the effects of inhaled substances on 
normal individuals with regard to symptoms they experience and the effect of their 
symptoms on quality of life. 
 
Many airborne chemical substances with an odor may produce sensory irritation in the eyes, 
nose and throat, as well as acute neurotoxic symptoms.  Such symptoms are dose related and 
all persons experience them.  Some persons who sense the odor from certain chemical 
substances may feel ill, although this reaction is not experienced by others with the same 
exposure.  Irritant symptoms may arise in environments in which inhaled substances are at 
levels lower than regulation levels,2 and  some say that chemical sensitivity is due to 
inadequate exposure limits for chemicals.3  Only a few epidemiologic studies from different 
work places have been performed to study this phenomenon.4  It is important to understand 
this phenomenon to protect workers properly. 
 
Individuals may incur great personal costs in order to ease their symptoms, whatever the 
cause or the current term for their symptoms or whether they incur the symptoms at home or 
work.  Studies have shown that workers have had to change jobs4 or are perhaps drawn or 
pushed into other jobs5 because they could not tolerate the symptoms they sustain when 
exposed to odors and irritants at work.   
 
The field of odor and irritant sensitivity requires understanding the contributions of many 
authors in the fields of anatomy, physiology, pathophysiology, and psychology. The 
literature covering this phenomenon is huge.  A basic problem facing the study of sensitivity 
to inhaled substances is determining if the symptoms occur due to psychological factors or 
physiological factors.  Broadly, areas of investigation include olfactory physiology, 
respiratory physiology, and psychology. 
 
People are exposed to airborne substances at home and at work.  Many of these substances 
not only produce an odor but can evoke ocular, nasal and throat irritation, as well as 
neurotoxic symptoms.  It is useful to define the airborne substances of interest as odors or 
irritants.  Briefly, odors stimulate the olfactory nerve (cranial nerve I).  Irritants cause 
inflammatory effects.6  Lateralization testing demonstrates this difference.  Single nostril 
stimulation with an irritant causes lateralization.  That is, one can tell into which nostril the 
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stimulus is applied in the case an irritant, such as ammonia.  An odor, however, infused into 
one nostril is sensed bilaterally.7  Many substances have odorous and irritant properties, but 
not all substances that are irritating are odorous (NO2),8 and not all odorous substances are 
irritating (phenyl ethyl alcohol).2  Irritant substances may be a simple molecule, such as 
acrolein and ozone or a complex mixture, such as tobacco smoke.9  However, inhaled odors 
and irritants can elicit complaints of eye, nose, and throat irritation, headache, nausea, 
diarrhea, hoarseness, sore throat, cough, chest tightness, nasal congestion, palpitations, 
shortness of breath, stress, drowsiness, and alterations in mood.8  The number of individuals 
who suffer from these symptoms is not known accurately, as estimates of the prevalence of 
this chemical sensitivity range from about 11 million10 to 90 million11 individuals.  The 
difference in prevalence is likely due to different case definitions. 
 
The field studying sensitivity to inhaled substances suffers from the lack of a consistent case 
definition or the name for phenomenon of sensitivity to inhaled substances,4 therefore, the 
results of studies are difficult to compare.  Odor perception is highly idiosyncratic, and this 
variability affects subjective responses.  Numerous factors, including adaptation, 
medications, aging, nutritional status, pregnancy, and a variety of diseases and disorders can 
affect odor perception.  Also, disorders of the olfactory system affect over 2.7 million 
Americans.7  Some of the symptoms of diseases such as asthma and allergic rhinitis overlap 
those symptoms developed after exposure to odors and irritants.  Furthermore, allergic 
symptoms can be exacerbated by non-allergenic inhaled substances.10, 12   
 
Although it may appear to be straightforward to expose individuals to a chemical and ask 
them to report on the level of irritation they experience, the potential for confusion between 
olfactory and irritant modalities has produced extreme variability in direct scaling of upper 
airway irritant sensations by individuals with intact olfactory and trigeminal systems.  This 
confusion is exacerbated when chemicals present in the air at levels that stimulate only odor 
sensation can prompt exposed individuals to report ‘irritation’, even if the perception is 
largely mediated through the psychological discomfort incurred by smelling the odor of an 
unfamiliar or unpleasant chemical, or even from misattributions of unrelated symptoms that 
happen to coincide with chemical exposure.2  More simply, subjects may report to 
researchers "irritation" by odors that are merely unpleasant or unfamiliar, so this study 
design yields confusing results. 
 
Psychologically, hypotheses have focused on psychiatric disorders, personality traits13, 14 and 
mass hysteria.15  Responses to inhaled chemicals are subjective, variable, and subject to 
suggestibility bias.  Suggestion and/or suggestibility bias effects were demonstrated in a 
study in which people given positive information about odors to which they were exposed 
had less perceived irritation compared to people given negative information.7  In another 
study, reports of sensory irritation in the workplace were influenced by the reactions of co-
workers and other bystanders to an odor.16  Instructing persons to attend to evidence of 
“nasal obstruction” as they breathed induced more symptoms than instructing them to attend 
to the “free passage of air.”  A significant amount of the variation in irritant and symptom 
perception in normal, healthy individuals can be attributed to differences in personality 
orientations.  Positive affective orientations appear to lower individuals' expectancies of 
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becoming ill, while negative orientations appear to heighten those same expectancies.2  
Although psychiatric causes may be an important source for symptoms, studies of patients 
with multiple chemical sensitivity showed no psychiatric diagnosis in up to 50%.13 
 
Demographic studies have shown that women, persons of relatively higher socioeconomic 
status, and in office rather than heavy industry positions are more likely to report symptoms 
from inhaled irritants.17  It is not understood why workers in heavy industry, who intuitively 
would have greater exposure to airborne chemicals, have less reported symptoms. 
 
Physiology affects irritant and odor perception.  Irritants typically obey a sigmoid dose-
response relationship with a threshold under which no irritation reaction occurs.  Many 
toxicological irritants show reversible effects – the inflammation disappears after exposure 
to the irritant ceases, however, acute exposures to high levels of some irritants can result in 
irreversible effects.9, 18  Human physiology can also affect this perception, as experiments 
have shown that odor intensity depends on the effort associated with inspiration.19 
Interestingly, research shows that odors are perceived to be more pleasant and odor 
identification is more accurate when smelled with the right nostril than with the left.20 
 
Study limitations aside, there are at least three mechanisms by which ambient odors may 
produce health symptoms.  First, symptoms can be induced by exposure to odorants at levels 
that also cause irritation or other toxicological effects.  That is, irritation, rather than the 
odor is the cause of the heath symptoms, and odor, the sensation, simply serves as an 
exposure marker.  Second, health symptoms from odorants at nonirritant concentrations can 
be due to innate (genetically coded) or learned aversions.  Third, symptoms may be due to a 
copollutant (such as endotoxin) that is part of an odorant mixture.4  A problem has 
developed, however, as there is a group of patients who have been given a diagnosis most 
commonly called Multiple Chemical Sensitivity.  The incidence of Multiple Chemical 
Sensitivity is said to be increasing.3, 17  It has been defined as, "an acquired disorder 
characterized by recurrent symptoms, referable to multiple organ systems, occurring in 
response to demonstrable exposure to many chemically unrelated compounds at doses far 
below those established in the general population to cause harmful effects.  No single widely 
accepted test of physiological function can be shown to be correlated with the symptoms.”21  
Media sources have sensationalized some aspects of this sensitivity by reporting on "sick 
buildings" and "20th Century Disease."  Once the media and legal system have reinforced to 
the general public that a product is dangerous, scientific evidence that comes after this 
process is not likely to be reassuring, and the misperception endures.22  Waddell's comments 
in 1992 are still true.  "The salient problem with MCS is that there is no consistent and 
specific effect from exposure to any specific chemical.  This does not allow for any 
objective test for any disease entity that might be caused by the chemicals as indicated by 
the theory of MCS.  The effects of exposure to chemicals as defined today by MCS are 
subjective, and no report is available to convincingly demonstrate that these effects would 
not have occurred merely by chance."23   
 
To summarize, odor and irritant perception is a complicated field of study, with 
disagreement about case definition, prevalence, and methodological problems that exist on 
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physiological and psychological levels.  It is obvious that this field needs more study in 
order to answer the question, "… is it the agents or the responder?"  To that end, we have 
created a questionnaire to identify normal individuals who seem to develop more severe 
symptoms from inhaled environmental odors, chemicals, and irritants.  These individuals 
may be suitable for further physiological studies in the Breath Laboratory at the University 
of South Florida.  Hopefully, this and further studies in this laboratory will help determine 
the cause of symptoms in this troubled population. 
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Methods 
 
The Institutional Review Board of the University of South Florida reviewed the study 
proposal and exempted the study from further review. 
 
This study describes the development and implementation of a self-administered 
questionnaire to demonstrate the frequency and severity of symptoms a normal adult 
population recalls when queried about their experience with exposure to four commonly 
encountered airborne odors and irritants -cigarette smoke, perfumes, automobile exhaust, 
and paint fumes - and relates these responses to their responses to quality of life queries.  
 
The questionnaire was presented to volunteers as part of a packet contained in a self-
addressed University of South Florida interoffice envelope from February 1, 2007, to 
February 28, 2007.  The envelope contained a cover letter (Appendix B), a 23 item 
demographic and medical questionnaire (Appendix C), and a two page 42 item symptom 
and quality of life questionnaire (Appendix D).   
 
The symptom questionnaire was created with input from consultants of the College of 
Industrial and Organizational Psychology at the University of South Florida, who have 
reviewed the questionnaire for readability and structure.  Quality of life items are derived 
from intuitive queries in addition to selected items from the Centers for Disease Control 
Prevention Health-Related Quality of Life 14 Item Measure's "Healthy Days Core 
Module."24  These items were included since they have been validated in other studies and 
increase the information contained in the data from ordinal to the interval level.  The 
medical questionnaire was used to define the study population after the results were 
returned.  It contained items concerning smoking history and medical and psychological 
conditions that could cause interference with normal olfaction and irritant sensation, all of 
which were used as exclusion criteria.  The demographic portion of the questionnaire 
obtained sex and age information.  No personally identifiable information was obtained.  
Information on age was used to study adults from 18 to 80 years old.  The entire 
questionnaire took about 10 minutes to present and complete. 
 
The questionnaire itself asked respondents to rate their likelihood of agreement with 
statements relating to symptoms they experienced when they encountered cigarette smoke; 
strong smells; cologne, perfumes or scented candles; automobile exhaust; or paint fumes in 
the past year.  The responses were scored on a 5-point Likert scale (1 = almost never; 5 = 
almost always).  The questionnaire contained subscales for ear, nose, and throat, lower 
respiratory, general, gastrointestinal, and neuropsychological symptoms.  To simplify 
symptom scoring, the form of the statements is such that agreement with the experience of 
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symptoms results in a higher Likert score.  In that way, more agreement with the statements 
resulted in higher raw symptom scores.  In this questionnaire, two formats were compared to 
each other to quantify quality of life.  In one format, four items were on a Likert scale, and 
in the other format based on the CDC items, 3 items were in a fill in the blank format, which 
will be referred to henceforth as “CDC styled” items.   
 
Volunteers were obtained by submitting the questionnaire to male and female staff and 
students of the College of Public Health at the University of South Florida during business 
hours, personally delivered by the Principal Investigator.  A kiosk in the College of Public 
Health was also used to attract volunteers from student and staff traffic in the lobby of the 
College of Public Health, also attended by the Principal Investigator.  A flyer on the kiosk 
was used to attract attention and provide initial information to potential volunteers.  
Professors allowed the questionnaire to be distributed to a class in two cases.   
 
Using standard deviation from the mean to define "high" and "low" scores, Magnavita15 was 
able to demonstrate a significant difference (p<0.001) in total symptom scores between 
cacosmic and noncascomic patients in a population of 47 subjects.  We proposed, then, to 
obtain 50 included subjects by submitting 100 questionnaires, expecting to exclude about 
half of the returned questionnaires.   
 
Volunteers were asked to respond to the questionnaire and mail their results via inter-office 
mail to the College of Public Health inbox, addressed to the principal investigator.  The 
subjects completed the questionnaire privately in order to minimize social acceptability bias.  
A new pencil with the USF logo (value ≈ $0.50) was enclosed in the envelope with the 
questionnaire to compensate respondents for their time to complete the questionnaire.   
 
In order to protect the privacy of participants, exclusion from analysis was performed after 
the questionnaires were returned.  Responses were excluded if any of the items were 
answered positively in the medical questionnaire, except for one item, #3, which asked if the 
respondent considered themselves a healthy person.  Items that were left blank on the 
Medical and Demographic portion of the questionnaire were considered a positive response 
and resulted in exclusion from the normal group.  All raw data has been dated and filed in a 
locked cabinet in the Respiratory Laboratory in the College of Public Health for two years, 
and then destroyed.  Respiratory Laboratory personnel will hold the key. 
 
Quality of life was measured by 4 questions with Likert scales and with 3 questions using 
CDC styled items.  The responses on the Likert format were summed to achieve a quality of 
life score, and the CDC styled questions were added to obtain another quality of life score.  
The possible range of values for summed Likert responses is 4 to 20.  The possible range of 
values for the CDC styled scores was 0 to 90.  Each of these scores were compared to total 
symptom scores to determine the relationship between quality of life scores and total 
symptom scores in response to inhaled odors, chemicals, and irritants, using simple linear 
regression.   
 
 8
Statistical calculations were performed using Microsoft Excel 2003.  A symptom score with 
a possible range of 29-145 was obtained by summing the symptom ratings for each included 
subject.  Scores for the five symptom groups were obtained by selecting the items 
corresponding to each system and summing the responses by system. 
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Results 
 
Ninety-six questionnaires were submitted to volunteers, and 82 were returned.  Fifty 
respondents identified themselves as female, and 28 identified themselves as male.  Four 
respondents did not specify age or sex.  Median age for all respondents was 31 years, 
ranging from 17 to 73.  (Table 1)  For reference, all items were numbered from the first 
demographic item, through the medical exclusion items, through the symptom items, and 
through the final quality of life items.  These numbers appear in the far left column in the 
appended questionnaires. 
 
Table 1:  Demographic Summary for All Respondents 
 
 n Lowest Age Median Age Highest Age 
All 82 17 31 73 
Males 28 18 33.5 73 
Females 50 17 29 61 
Unspecified 4    
 
The intended group of respondents for this study, the inclusion group, were obtained by 
using the responses given on the Medical and Demographic Information page (Appendix C) 
to obtain a population without major physiological or psychological disease between the 
ages of 18 and 80.  Four responses had data of such poor quality they were excluded on this 
basis alone.  Exclusion criteria removed 55 more responses, leaving 23 responses included 
for further statistical analysis, which was called the normal sample.  The inclusion group 
consisted of 13 females, 9 males and one unspecified age and sex.  The median age for all 
normal respondents for which data was specified was 26, ranging from 18 to 47.  (Table 2) 
 
Table 2:  Demographic Summary for Normal Respondents 
 
 n Lowest Age Median Age Highest Age 
All 23 18 26 47 
Males 9 18 28 38 
Females 13 19 27 47 
Unspecified 1    
 
 
Total symptom scores for the inclusion group were derived from a Likert scale and thus 
treated as ordinal variables.  These scores ranged from 35 to 106, representing the sum of all 
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Likert responses to specific symptom queries.  The median score is 63.5.  The frequency 
distribution of symptom scores is shown in Figure 1. 
 
Figure 1:  Histogram of Total Symptom Scores in Normal Respondents 
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The quality of life scores for the inclusion group ranged from 4 to 10 on the Likert scaled 
items, out of a possible range of 4 to 20, representing the sum of responses to each of the 4 
Likert items.  A histogram of the quality of life scores on the Likert scale is shown in Figure 
2.  Increasing values on the Likert scale represented diminishing quality of life. 
 
Figure 2:  Histogram of Likert Quality of Life Scores in the Inclusion Group 
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The histogram in Figure 3 shows the frequency of responses to the fill in the CDC styled 
quality of life scores in the inclusion group.  Three responses from the above group of Likert 
respondents were not included in Figure 3 due to missing data.  Increasing QOL score is in 
the direction of more days of disability. 
 
Figure 3:  Histogram of CDC Styled Quality of Life Scores  
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The adjusted Spearman rank correlation = .463 for the relationship between Likert-type 
items and the CDC styled items in the inclusion group.  The scatter plot of the raw quality of 
life scores is represented in Figure 4. 
 
Figure 4:  Scatter Plot of Likert versus CDC Styled Responses 
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To show the relationship between quality of life score and symptom score, each of the two 
types of quality of life (Likert and CDC styled) scores were compared to total symptom 
scores in the normal patients.  Again, there are three less comparisons in the CDC styled 
comparison than the Likert formatted items due to missing data.  The relationship between 
the Likert styled items and symptom scores in normal patients yields an adjusted Spearman 
rank correlation = .916.  The scatter plot and the best fit regression line for these points are 
in Figure 5. 
 
Figure 5:  Scatter Plot of Symptom Score versus Likert Quality of Life Scores 
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When the CDC styled quality of life scores are compared with the symptom scores, the 
regression function gives an adjusted Spearman rank correlation =  0.725.  These data are 
represented in Figure 6 with a trendline showing the best fit for the regression function 
between the variables. 
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Figure 6:  Scatter Plot of Symptom Score versus CDC Styled Quality of Life Score 
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The responses in each symptom group were averaged to give a system score, and the sum of 
these averages gave an adjusted symptom score that adjusted for the number of items in each 
symptom group, which ranged from 4 to 9 items.  This controlled for the different weights 
given to the total symptom score due to the different number of items in each symptom 
group.  The unadjusted and adjusted total symptom scores were very similar, with adjusted 
Spearman correlation coefficient between the two scores = 0.99.  The possible adjusted 
symptom score ranged from 5 to 25.  The 5 symptom groups were compared by relating 
their average score to the adjusted symptom score.  This was done for several subsets of the 
responses, including the inclusion group, the excluded group, an “atopic group”, and 
smokers.  These populations are not necessarily exclusive.  The excluded group consisted of 
all responses between the ages of 18 and 80 that are not in the inclusion group.  The “atopic 
group” consists of all excluded responses that would have been in the inclusion group but 
for a positive response to the items, “Do you get hay fever, seasonal allergies, or allergic 
rhinitis?” or “Do you have eczema or hives?” Smokers were defined as those excluded, but 
which would have been in the inclusion group except for a positive response on the items, 
“Are you a smoker?” or “Have you smoked in the last 10 years?”.  Adjusted Spearman 
correlation coefficients for these relationship between the system symptom score and the 
total adjusted symptom score are presented in Table 3.  LoResp represents the lower 
respiratory system, and NeuroP represents neuropsychological symptoms. 
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Table 3:  Correlation Coefficients of Symptom Group with Adjusted Symptom  
Score 
 
 Normal Excluded Atopic Smokers Average 
General 0.86 0.87 0.75 0.73 0.80 
ENT 0.92 0.83 0.90 0.91 0.89 
GI 0.93 0.76 0.24 0.89 0.71 
LoResp 0.66 0.91 0.48 0.95 0.75 
NeuroP 0.80 0.44 0.81 0.62 0.67 
Average 0.83 0.76 0.64 0.82 0.76 
 
The symptom scores of these patient groups were compared to the Likert and CDC styled 
quality of life scores.  The adjusted Spearman correlation coefficients for the Likert styled 
items appear in Table 4, and for the CDC styled items in Table 5. 
 
Table 4:  Correlation Coefficients of Symptom Group with Likert Styled Quality  
of Life Items 
 
 Normal Excluded Atopic Smokers Average 
General 0.84 0.79 0.43 0.81 0.72 
ENT 0.89 0.86 0.07 0.85 0.67 
GI 0.88 0.70 0.64 0.82 0.76 
LoResp 0.49 0.90 0.52 0.82 0.68 
NeuroP 0.80 0.77 0.48 0.77 0.70 
Average 0.78 0.80 0.43 0.81 0.71 
 
Table 5:  Correlation Coefficients of Symptom Group with CDC Styled   
Quality of Life items 
 
 Normal Excluded Atopic Smokers Average 
General 0.65 0.11 -0.31 0.26 0.18 
ENT 0.72 -0.05 -0.33 0.00 0.09 
GI 0.60 0.04 -0.13 0.00 0.13 
LoResp 0.35 0.04 -0.46 0.07 0.00 
NeuroP 0.65 -0.19 -0.30 0.26 0.11 
Average 0.59 -0.01 -0.31 0.12 0.10 
 
The Mann-Whtney U test was used to determine the probability that the distributions of the 
different symptom groups in the different patient groups were different than that of the 
inclusion group.  The p values are presented in Table 6: 
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Table 6:  Probability of Difference from Inclusion Group 
 
 Excluded Atopic Smokers 
General 0.00 0.23 0.08 
ENT 0.01 0.01 0.19 
GI 0.31 0.25 0.73 
LoResp 0.10 0.49 0.07 
NeuroP 0.27 0.22 0.07 
 
 
 
Items # 25 – 28 asked about respondents' reaction to cigarette smoke, automobile exhaust, 
strong smells, cologne, perfumes or scented candles, and fresh paint vapors or fumes (the 
substances in the table below).  These responses were summed and compared with the 
symptom scores of the different patient groups.  The adjusted Spearman correlation 
coefficients are shown in Table 7: 
 
Table 7:  Correlation Coefficients of Substances with Patient Groups 
 
 Normal Excluded Atopic Smokers 
Cigarette 0.21 0.49 0.48 0.27 
Exhaust 0.12 0.40 0.23 0.17 
Scents 0.11 0.50 0.60 0.52 
Paint 0.18 0.50 0.47 0.27 
 
General health was queried twice, using two different formats.  The first format gave a 
yes/no choice, and the second gave a 5 level Likert range of responses.  In all cases, items 
answered "yes" to the query whether the respondent considered themselves a healthy person 
were answered from 1-3 in the Likert scale, representing excellent, very good, and good 
health.  All "no" answers in the yes/no format were answered from 4 to 5 in the Likert 
representation of the query, representing fair or poor health.  The adjusted Spearman 
correlation coefficient of this relation = .363. 
 
There was a group of 15 respondents who were labeled "atopic", as they were excluded from 
the normal group only by their positive response to the items on the medical portion of the 
questionnaire relating to asthma, antihistamine use, hay fever, and eczema.  The median 
symptom score for this “atopic” group was 65 (n = 15), and it was 54 (n = 23) for the normal 
group.  Wilcoxon's two group rank-sum method25 was used to test the hypothesis that the 
means of the groups were the same.  The difference in the groups was significant for the two 
tailed test at α = 0.1, with obtained t = 3.53 and critical t = 2.673. 
 
The Mann-Whitney U test was used to determine the likelihood that patient groups’ 
distribution of symptom scores and quality of life scores (on the two different quality of life 
styles) differed from the inclusion group scores.  These are presented in Tables 8 and 9. 
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Table 8:  Probability of Different Distribution from Inclusion Group Symptom  
Scores 
 
Excluded 0.23 
Atopic 0.16 
Smokers 0.03 
 
Table 9:  Probability of Different Distribution from Inclusion Group  
Quality of Life Scores 
 
 LQOL CQOL 
Excluded 0.40 0.37 
Atopic 0.30 0.39 
Smokers 0.12 0.28 
 
Symptom scores for males were significantly less than those for females only in the 
inclusion group, with a one tailed p = 0.048.  This same test shows that the mean symptom 
scores are not significantly different for males and females in the normal group, where p = 
0.5 for the difference. 
 
The adjusted Spearman’s rank correlation coefficient relating age with total symptom scores 
= .239 in the normal group and = -.054 in the excluded group. 
 
Item # 24 asked respondents to identify their agreement with the statement, "I am more 
sensitive to inhaled chemicals, irritants, odors, or strong fragrances than the average person."  
The adjusted Spearman’s rank correlation coefficients relating the response to this single 
item to the symptom groups in the different patient groups in Table 10. 
 
Table 10:  Correlation coefficients between Item 24 and Symptom Group in Various  
Patient Groups 
 
 Normal Excluded Atopic Smokers Average 
General 0.30 0.41 0.47 -0.03 0.29 
ENT 0.54 0.39 0.43 0.36 0.43 
GI 0.38 0.27 -0.04 0.42 0.26 
LoResp 0.09 0.45 0.42 0.47 0.36 
NeuroP 0.36 0.46 0.69 0.17 0.42 
Average 0.33 0.40 0.40 0.28 0.35 
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Discussion 
 
Demographic comparison showed a similar age distribution between males and females, but 
female respondents numbered twice those of males, reflecting the student population of the 
College of Public Health at the University of South Florida. 
 
The statistical analysis of the data in this cross-sectional study show that there is a bimodal 
distribution of symptom scores that adults between the ages of 18 and 80 without 
confounding disease states (the inclusion group) reports on their experience with cigarette 
smoke, automobile exhaust, strong smells, cologne, perfumes or scented candles or fresh 
paint vapors or fumes.  This could represent a physiologic difference in individuals in the 
two groups, the normal individuals without symptoms and the normal individuals with 
symptoms.  The nadir of the curve between modes provides a good point to divide "normal - 
asymptomatic" and "normal - symptomatic" responses.  This point would be a total 
symptom score somewhere between 65 and 70, as this score seems to discriminate between 
the groups on gross inspection of the histogram of symptom scores. 
 
The quality of life scores obtained from the Likert scale items in this included group 
correlate fairly well with symptom scores, whereas the quality of life scores from the fill in 
the blank items correlate less well with symptom scores.  Also, the quality of life scores 
from the two different item formats correlate poorly with each other.  None of the system 
subscores agreed well with the CDC styled quality of life in any patient group other than the 
inclusion group. 
 
The hypothesis that increasing symptoms affects the health-related quality of life was 
supported, as shown in Figures 5 and 6, where the regression slope is not zero, but is 
positive in this case.  This shows that increasing symptoms result in decreased health related 
quality of life perceptions.   
 
On average, of all the symptom categories, ear, nose, and throat symptoms correlated best 
with total symptom scores, and neuropsychological symptoms correlated least well.  High 
correlation of the total symptom score with ENT symptoms may result from the fact that this 
system is likely evolved to detect inhaled odors, chemicals, and irritants.  
 
Interestingly, the quality of life scores for the atopic individuals was very poorly correlated 
with quality of life.  Perhaps the symptoms of atopy have incorporated into the background 
sensations of these individuals to the point that these symptoms are not perceived as severe 
enough to report. 
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The only patient group system scores that differed at the 0.05 level of significance from the 
inclusion group was the General and ENT scores in excluded respondents and ENT scores in 
the atopic group. 
 
Item # 24, regarding the overall question regarding one’s perceived sensitivity to odors, 
chemicals, and irritants correlated fairly well with final symptom scores in all groups.   
 
Magnavita, in his study of odor sensitivity in healthy workers, asked food store workers to 
rate the likelihood that each of 10 substances were able to cause them symptoms of physical 
illness.  He found that self-identified odor intolerance was significantly associated with the 
frequency of physical symptoms.  Pearson product-moment calculations in the present study 
agree with this conclusion, finding a coefficient = 0.55 between the item asking if an 
individual considered himself sensitive to odors, chemicals, and irritants, and their total 
symptom score.  He also found that females developed symptoms more frequently than 
males without regard to preexisting disease.  A similar analysis of our data shows the same 
effect when exclusions in this study are not applied, similar to his method.   
Comparisons between similar information asked at different points or asked a different way 
are useful to assess internal validity.  There was agreement in direction of the answers to the 
items.  All those who felt they were generally healthy also agreed that they enjoyed good to 
excellent health.  All those who felt they were not generally healthy later agreed that they 
suffered fair or poor health. 
 
Biases in this questionnaire implementation include a severe selection bias.  This study 
sample represents a mostly young, ambulatory, healthy, educated population.  This reflects 
the environment in which it was distributed.  Males and females are not represented equally.  
The ethnic characteristics of this sample are not quantitatively known, but qualitatively, it 
can be said that the respondents were of several different ethnicities, including African, 
Caucasian, Hispanic, Black American, and Asian, with Caucasian representing the great 
majority of respondents.  This will affect external generalization.  As experience with the 
questionnaire grows, and the population to which it is submitted broadens, external 
generalizability will become more possible. 
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The Final Questionnaire 
 
This questionnaire was a pilot study to create a final questionnaire to inexpensively identify 
normal respondents who may suffer from symptoms when exposed to inhaled odors, 
chemicals, and irritants in a stronger way than other normal individuals.  This is to select 
those for physiological testing that are more likely to demonstrate a physiological difference 
when tested by inhalation challenge, which satisfies in part the ethical duty to minimize risks 
to those not likely to benefit from investigation.   
 
After analysis of this pilot questionnaire, it can be simplified and it needs modification.   
 
Several respondents reflected the teaching in the College of Public Health that sex does not 
equal gender, and the more appropriate question in this item would be gender. 
 
Item # 3, asking, “Do you consider yourself a healthy person?”, can be dropped, as it is such 
a general query it should not result in inclusion or exclusion in the normal group; that is, a 
volunteer’s responses should not be segregated into the exclusion group if this were the only 
item answered positively on the medical questionnaire of exclusion criteria. 
 
Only one respondent reported an abnormal sense of taste and a normal sense of smell.  All 
other cases would have been excludable on the basis of abnormal sense of smell only.  Also, 
the sense of taste is not critical to sensations of odors, chemicals, and irritants, so it (Item # 
11) can be dropped.   
 
Consideration should be given to dropping the item on heart disease (Item # 14).  The item 
asking about heart medication should be more specific, as some respondents may consider 
antihypertensive medication to be "heart medication", yet hypertension per se does not 
indicate heart disease.  This problem is magnified by the relatively high prevalence of 
antihypertensive treatment compared to the prevalence of significant heart disease.  If Item # 
14 is kept, it should be preceded by an item asking about hypertension, such as "Do you take 
medicine for high blood pressure?".  Also, it is not critical that persons with heart disease are 
excluded from the normal group, as there is no known link between heart disease and 
perception of inhaled odors, chemicals, and irritants.  Excluding respondents on the basis of 
this disease may be too restrictive.   
 
The item regarding psychiatric disorders (Item # 19) should be more specific to definitely 
include those suffering from depression, which has been shown to influence responses to 
inhaled odors.  Antidepressant therapy could be used as a proxy for the diagnosis of 
significant depression.  It would be more accurate than self-diagnosis of depression without 
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developing another questionnaire to merely establish this point.  The proposed items for this 
medical item are A:  "Do you take medicine for depression?" and B:  "Do you suffer from 
any other psychiatric disorder?"  A positive response to either should result in exclusion 
from the normal group. 
 
Near-identical responses to similar symptoms can be simplified by throwing out one or the 
other.  These are the burning (Item # 31) and tingling (Item # 32) of the face items.  They 
elicited identical responses, and therefore one is predictive of the other 100% of the time, so 
either can be discarded.  As few agreed with either statement, both could be dropped.   
 
Item # 61 is moved upward in the item bank to follow the other symptoms and allow the 
quality of life items to finish the section in order to ease analysis and scoring. 
 
Two scales were tested to indicate quality of life.  The Likert styled items, as they correlated 
more closely with symptom scores than the CDC styled items, should be used if quality of 
life is to be measured in the future.  Therefore, in the final version, Items # 62-65 are 
dropped. 
 
(Appendix E)  The final exclusion panel changes are shown in gray.  It will consist of 20 
items, including age and gender.  The final symptom questionnaire, excluding quality of life 
items, will consist of 33 items.  It is expected that, using the considerations above, this 
simpler questionnaire will retain the ability of the pilot questionnaire to detect the frequency 
and severity of symptoms reported by normal individuals on their experience with odors, 
chemicals, and irritants, and relate that with their quality of life. 
 
As the items that were excluded from the symptom queries were mostly removed due to low 
prevalence of positive responses, the dividing symptom score between normal and 
responsive normal subjects can continue to be somewhere between 65 and 70 until the 
distributions are better defined for the symptom scores. 
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Appendix A:  Flyer.   
Formatting altered to fit format constraints. 
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Appendix B:  Cover Letter 
 
To the volunteer: 
 
I am inviting you participate in a research project to study symptoms that one develops after 
exposure to airborne irritants. Along with this letter is a short questionnaire that asks a 
variety of questions about this.  I am asking you to look over the questionnaire and, if you 
choose to do so, complete it and send it back to me using the interoffice envelope in which it 
came.  It should take you about 15 minutes to complete. 
 
The results of this project will be used to refine this questionnaire so it can be used to 
identify subjects for further study. Through your participation, I hope to identify those 
questions that are most and least useful.  The development and results of this study will be 
used as the subject of my Masters Thesis in the College of Public Health. 
 
I do not know of any risks to you if you decide to participate in this survey, and I guarantee 
that your responses will not be identified with you.  I promise not to share any information 
that identifies you with anyone.  You should not volunteer to put your name or any other 
information on the questionnaire other than that which is requested.  If you do not feel 
comfortable completing the survey, discard it. 
 
The survey should take you about 15 minutes to complete.  I hope you will take the time to 
complete this questionnaire and return it.  Your participation is voluntary, and there is no 
penalty if you do not participate.  Regardless of whether you choose to participate, the 
results will be on file at the University of South Florida Shimberg Health Sciences Library 
after April 7, 2007. 
 
If you have any questions or concerns about completing the questionnaire or about being in 
this study, you may contact me at (813) 943-7960.  Alternatively, if you have questions 
about your rights, general questions, complaints, or issues as a person taking part in this 
study, you may also call the Division of Research Integrity and Compliance of the 
University of South Florida at (813) 974-9343.    
 
Sincerely, and thank you, 
 
signature 
   
Stephen E. Williamson, M.D. 
Chief Investigator 
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Appendix C:  Medical and Demographic Information. 
Formatting altered to fit format constraints. 
 
 Demographics and History 
  
1 Sex   
 
2 Age      
 
 
  
 Please place an "X" in the appropriate box below 
   
  Yes No 
3 Do you consider yourself a healthy person?     
4 Do you take antihistamines?     
5 Do you get hay fever, seasonal allergies, or allergic rhinitis?     
6 Do you cough every day?     
7 Do you suffer from respiratory problems?     
8 Do you have asthma?     
9 Are you a smoker?     
10 Do you have a normal sense of smell?     
11 Do you have a normal sense of taste?     
12 Have you smoked in the last 10 years?     
13 
Have you received systemic steroids or antibiotics within the past 4 
weeks?     
14 
Do you have congestive heart failure, cardiomyopathy, valvular 
heart disease, angina, cardiac arrhythmia, or had a myocardial 
infarction within the last 6 months?     
15 Are you taking heart medication?     
16 Do you have hepatitis or cirrhosis?     
17 Do you suffer from renal failure?     
18 Do you suffer from any neurologic disorder?     
19 Do you suffer from any psychiatric disorder?     
20 Are you pregnant or think you might be?     
21 Do you have eczema or hives?     
22 Do you have arthritis?     
23 
Has a doctor ever told you that you have fibromyalgia, chronic 
fatigue syndrome, or multiple chemical sensitivity?     
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Appendix D:  Symptom and Quality of Life Questionnaire. 
Formatting altered to fit format constraints. 
 
  
 Chemical, Odorant And Irritant Sensitivity Questionnaire 
  
 This questionnaire asks about how you feel now and over the past year. 
  
 Please check the box that most closely describes how you feel. 
  
 
   
Strongly 
Disagree 
Disagre
e 
Uncertai
n 
Agree Stron
gly 
Agree 
24 
I am more sensitive to inhaled 
chemicals, irritants, odors, or 
strong fragrances than the 
average person           
   
 
If I am around the following I 
get this reaction: 
Nothing 
unusual 
I am 
bothere
d 
A mild 
reaction 
Become 
some- 
what ill  
Beco
me 
very 
Ill 
25 Cigarette smoke           
26 Automobile exhaust           
27 
Strong smells, cologne, perfumes 
or scented candles            
28 Fresh paint vapors or fumes           
 
   
 
If I am exposed to cigarette smoke, automobile exhaust, strong smells, perfumes or 
colognes, or fresh paint vapors: 
 
   
Strongly 
Disagree 
Disagre
e 
Uncertai
n 
Agree Stron
gly 
Agree 
29 I suffer discomfort           
30 I become sick           
31 
I develop burning in the skin of 
my face           
32 
I develop tingling in the skin of my 
face           
33 
I develop a funny sensation of the 
skin of my face           
34 I develop eye irritation           
35 I develop eye pain           
36 I develop eye itching           
37 I develop sore or burning nasal           
 29
passages 
38 
I develop burning in my nasal 
passages           
39 I develop a sore throat           
40 I feel nauseated           
41 I develop indigestion           
42 I develop diarrhea           
43 I get gas           
44 I may cough           
45 I may cough phlegm up           
46 I feel like I can't get my breath.           
47 I start wheezing           
48 
I feel tightness or pressure in my 
chest           
 
 
   
 Continued on next page 
 
If I am exposed to cigarette smoke, automobile exhaust, strong smells, perfumes or 
colognes, or fresh paint vapors: 
 
   
Strongly 
Disagree 
Disagre
e 
Uncertai
n 
Agree Stron
gly 
Agree 
49 I develop aching joints           
50 I develop trouble sleeping           
51 
I develop numbness or tingling in 
my hands or feet           
52 My body feels hot or cold           
53 I become emotional           
54 I get a headache           
55 I become anxious           
56 I have trouble concentrating           
57 I miss work           
58 
I miss social or business 
appointments           
59 I feel stress at home or work           
60 
I find it hard to interact with other 
persons           
61 
My symptoms ease if I can get 
away           
 
   
  Excellent
Very 
good Good Fair  Poor 
62 
Would you say that in general 
your health is:           
   
 30
63 
Now thinking about your physical 
health, which includes physical 
illness and injury, for how many 
days during the past 30 days was 
your physical health not good?   
64 
Now thinking about your mental 
health, which includes stress, 
depression, and problems with 
emotions, for how many days 
during the past 30 days was your 
mental health not good?   
65 
During the past 30 days, for about 
how many days did poor physical 
or mental health keep you from 
doing your usual activities, such 
as self-care, work, or recreation?       
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Appendix E:  Proposed Revised Medical and Demographic Information 
 
 Demographics and History 
  
1 Sex Gender   
 
2 Age      
 
 
  
 Please place an "X" in the appropriate box below 
   
  Yes No 
3 Do you consider yourself a healthy person?     
4 Do you take antihistamines?     
5 Do you get hay fever, seasonal allergies, or allergic rhinitis?     
6 Do you cough every day?     
7 Do you suffer from respiratory problems?     
8 Do you have asthma?     
9 Are you a smoker?     
10 Do you have a normal sense of smell?     
11 Do you have a normal sense of taste?     
12 Have you smoked in the last 10 years?     
13 
Have you received systemic steroids or antibiotics within the 
past 4 weeks?     
14 
Do you have congestive heart failure, cardiomyopathy, valvular 
heart disease, angina, cardiac arrhythmia, or had a myocardial 
infarction within the last 6 months?     
15 Are you taking heart medication?     
16 Do you have hepatitis or cirrhosis?     
17 Do you suffer from renal failure?     
18 Do you suffer from any neurologic disorder?     
19 Do you suffer from any psychiatric disorder?     
 Do you take medication for depression?     
20 Are you pregnant or think you might be?     
21 Do you have eczema or hives?     
22 Do you have arthritis?     
23 
Has a doctor ever told you that you have fibromyalgia, chronic 
fatigue syndrome, or multiple chemical sensitivity?     
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Appendix F:  Proposed Revised Symptom and Quality of Life Questionnaire 
 
  
 Chemical, Odorant And Irritant Sensitivity Questionnaire 
  
 This questionnaire asks about how you feel now and over the past year. 
  
 Please check the box that most closely describes how you feel. 
  
 
   
Strong
ly 
Disagr
ee 
Disa
gree 
Unce
rtain 
Agree Strongly 
Agree 
24 
I am more sensitive to inhaled 
chemicals, irritants, odors, or 
strong fragrances than the 
average person           
   
 
If I am around the following I get 
this reaction: 
Nothin
g 
unusu
al 
I am 
both
ered 
A 
mild 
react
ion 
Become 
some- 
what ill  
Become 
very Ill 
25 Cigarette smoke           
26 Automobile exhaust           
27 
Strong smells, cologne, perfumes 
or scented candles            
28 Fresh paint vapors or fumes           
 
   
 
If I am exposed to cigarette smoke, automobile exhaust, strong smells, 
perfumes or colognes, or fresh paint vapors: 
 
   
Strong
ly 
Disagr
ee 
Disa
gree 
Unce
rtain 
Agree Strongly 
Agree 
29 I suffer discomfort           
30 I become sick           
31 
I develop burning in the skin of my 
face           
32 
I develop tingling in the skin of my 
face           
33 
I develop a funny sensation of the 
skin of my face           
34 I develop eye irritation           
35 I develop eye pain           
36 I develop eye itching           
37 
I develop sore or burning nasal 
passages           
38 
I develop burning in my nasal 
passages           
 33
39 I develop a sore throat           
40 I feel nauseated           
41 I develop indigestion           
42 I develop diarrhea           
43 I get gas           
44 I may cough           
45 I may cough phlegm up           
46 I feel like I can't get my breath.           
47 I start wheezing           
48 
I feel tightness or pressure in my 
chest           
 
 
   
 Continued on next page 
 
If I am exposed to cigarette smoke, automobile exhaust, strong smells, 
perfumes or colognes, or fresh paint vapors: 
 
   
Strong
ly 
Disagr
ee 
Disa
gree 
Unce
rtain 
Agree Strongly 
Agree 
49 I develop aching joints           
50 I develop trouble sleeping           
51 
I develop numbness or tingling in 
my hands or feet           
52 My body feels hot or cold           
53 
My symptoms ease if I can get 
away Moved from item 61 to new position 
54 I become emotional           
55 I get a headache           
56 I become anxious           
57 I have trouble concentrating           
58 I miss work           
59 
I miss social or business 
appointments           
60 I feel stress at home or work           
61 
I find it hard to interact with other 
persons           
       
 
 
Delete the following if quality of life is assessed.  Use above Likert styled 
items, # 58-61 
    
Excell
ent 
Very 
good 
Goo
d Fair  Poor 
62 
Would you say that in general your 
health is:           
    
63 Now thinking about your physical 
health, which includes physical 
illness and injury, for how many 
days during the past 30 days was 
  
  
  
 34
your physical health not good? 
64 
Now thinking about your mental 
health, which includes stress, 
depression, and problems with 
emotions, for how many days 
during the past 30 days was your 
mental health not good?   
65 
During the past 30 days, for about 
how many days did poor physical 
or mental health keep you from 
doing your usual activities, such 
as self-care, work, or recreation?   
 
 
 
